SolarCity more than doubled its loss vs. a year earlier, while revenue fell short of Q2 analyst estimates. But shares extended gains late Thursday as the No. 1 U.S. residential solar installer said its customer base doubled. The San Mateo, Calif.-based company lost 96 cents a share on soaring expenses vs. a 43-cent loss a year earlier. Analysts polled by Thomson Reuters had expected a loss of 99 cents. Revenue rose 62% to $61.3
Chinese online social platform YY late Wednesday reported Q2 earnings and sales that beat analyst estimates, with online music and entertainment revenue tripling as that unit’s growth accelerated. The company’s revenue forecast for the current quarter also beat expectations. But YY (YY)’s number of paying game users slipped 5% from Q1 and its display ad revenue — which is less than 5% of total revenue — declined 5%. YY stock
Four highly rated drugmakers beat analysts’ second-quarter estimates Tuesday, but they generally followed this season’s trend of guiding conservatively. Specialty/generics giant Actavis’ (ACT) earnings rose 70% vs. a year earlier to $3.42 a share, beating forecasts by 5 cents. Sales rose 34% to $2.67 billion, more than $100 million above estimates. The company offered its first guidance since it bought Forest Laboratories, which